KCNH1 and cancer: Over the past two decades, the voltage-gated potassium channel Kv10.1 has gained increasing relevance in oncology, as its expression is frequently high in a wide range of clinical cancer samples, while being absent in the corresponding non-tumoral tissues (Cázares-Ordoñez and Pardo, 2017; Luis et al., 2022a).